TTHX-1114 (Trefoil Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTTHX-1114 (Trefoil Therapeutics)
Drug Alias NameTTHX-1114 (Trefoil Therapeutics)TTHX-1114 (Trefoil Therapeutics)
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionFibroblast growth factor receptors agonists
TargetsFibroblast growth factor receptors
Therapy Area/IndicationsCorneal Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesTrefoil Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTrefoil Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCorneal Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A